Old Web
English
Sign In
Acemap
>
authorDetail
>
Keith A Szymanski
Keith A Szymanski
AstraZeneca
Medicine
Gout
Intensive care medicine
Marginal cost
Physical therapy
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dose Reductions and Discontinuations with Chronic Lymphocytic Leukemia (CLL) Patients Receiving Ibrutinib in Community and Academic Settings
2020
Blood
Jing-Zhou Hou
Kellie Ryan
Senxi Du
Bruno S. Fang
Stanley M. Marks
Ray Page
Eileen Peng
Keith A Szymanski
Sharon Winters
Hannah Le
Show All
Source
Cite
Save
Citations (1)
Budget impact of adding lesinurad for second-line treatment of gout: a US health plan perspective
2018
Journal of Comparative Effectiveness Research
Robert W. Klein
Shaum Kabadi
Frank N. Cinfio
Christopher A. Bly
Dc Taylor
Keith A Szymanski
Show All
Source
Cite
Save
Citations (1)
1